Company: MYGN
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0000899923-25-000086
Chunk: 11

Company: MYRIAD GENETICS INC
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 1
Chunk 11
---
Item 1.    Financial Statements.

MYRIAD GENETICS, INC.

AND SUBSIDIARIES

Condensed Consolidated Balance Sheets (unaudited)

(in millions)

June 30,2025December 31,2024ASSETSCurrent assets:Cash and cash equivalents$74.4 $102.4 Trade accounts receivable137.0 121.2 Inventory28.7 27.5 Prepaid taxes14.3 16.4 Prepaid expenses and other current assets29.9 30.5 Total current assets284.3 298.0 Operating lease right-of-use assets51.2 55.0 Property, plant, and equipment, net113.0 117.4 Intangibles, net170.1 262.4 Goodwill51.6 286.3 Other assets7.1 8.5 Total assets$677.3 $1,027.6 LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$30.9 $32.3 Accrued liabilities100.6 119.0 Current maturities of operating lease liabilities9.0 12.8 Current debt59.4 — Total current liabilities199.9 164.1 Unrecognized tax benefits1.2 32.7 Long-term debt— 39.6 Noncurrent operating lease liabilities86.2 87.9 Other long-term liabilities1.9 2.2 Total liabilities289.2 326.5 Commitments and contingenciesStockholders’ equity:Common stock, 93.1 and 91.3 shares outstanding at June 30, 2025 and December 31, 2024, respectively0.9 0.9 Additional paid-in capital1,474.7 1,457.8 Accumulated other comprehensive loss(0.1)(0.8)Accumulated deficit(1,087.4)(756.8)Total stockholders' equity388.1 701.1 Total liabilities and stockholders’ equity$677.3 $1,027.6 

See accompanying notes to Condensed Consolidated Financial Statements.

4

Table of Contents

MYRIAD GENETICS, INC.

AND SUBSIDIARIES

Condensed Consolidated Statements of Operations (unaudited)

(in millions